Iovance Biotherapeutics, Inc. (IOVA) Social Stream



Iovance Biotherapeutics, Inc. (IOVA): $15.43

0.48 (+3.21%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add IOVA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 395

in industry

Iovance Biotherapeutics Inc (IOVA) Price Targets From Analysts

Use the tables below to see what analysts covering Iovance Biotherapeutics Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-05 11 $60 $20 $39.7 $17.36 128.69%
2021-11-14 10 $60 $20 $39.7 $17.36 128.69%
2021-11-15 10 $60 $20 $39 $17.36 124.65%
2022-01-17 10 $60 $20 $37.9 $17.36 118.32%
2022-01-28 10 $60 $20 $38.1 $17.36 119.47%
2022-02-25 10 $60 $20 $36.8 $17.36 111.98%
2022-02-27 10 $60 $20 $36.3 $17.36 109.1%

The Trend in the Analyst Price Target


IOVA's average price target has moved down $15.7 over the prior 45 weeks.

Over the past 46 weeks, IOVA's average upside potential has been 85.34%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-05 14 83 18 40.75 17.92 127.4%
2021-09-20 14 86 18 40.31 24.00 67.96%
2021-11-05 11 60 20 39.70 25.00 58.8%
2021-11-15 10 60 20 39.00 19.59 99.08%
2021-12-22 10 60 20 37.90 19.83 91.12%

IOVA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.2 9 0 1 0 0 10

The Trend in the Broker Recommendations


IOVA's average broker recommendation rating improved by 0.8 over the prior 123 days.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, Iovance Biotherapeutics Inc's variance in analysts' estimates is lower than -551.38% of them.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, Iovance Biotherapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 592.6% of them.
  • IOVA has a greater number of analysts covering the stock than 565.77% of Pharmaceutical Products stocks.
  • In the context of Pharmaceutical Products stocks, Iovance Biotherapeutics Inc's average analyst price target is higher than 421.35% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Iovance Biotherapeutics Inc are IMVT, HALO, and FMTX.

What is the outlook for IOVA? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4578 seconds.